en · de · es · fr · pt
faq-desk.peptides6579.com › Topic › Semax Peptide Background And Identity — Reference Sheet

Semax Peptide Background And Identity — Reference Sheet

By Editorial Desk · published 2026-02-14 · last reviewed 2026-04-02 · Topic

A practical reference on ACTH(4-10): what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.

This page was last updated on 2026-04-02 and is reviewed periodically as new material appears.

Semax Peptide Background and Identity

Development is attributed to researchers at the Institute of Molecular Genetics in Moscow during the early 1980s, building on earlier Soviet work with ACTH fragments. Russian regulatory approval followed for intranasal use, and the compound has remained commercially available there for decades. Most published human data originate from Russian and, later, some Eastern European clinical reports, which are not always accessible in English translation. Outside that region the material is generally handled as a research chemical rather than a licensed medicine.

Regulatory status differs sharply between jurisdictions. In Russia the peptide is registered as a prescription nasal preparation, while agencies such as the United States Food and Drug Administration have not approved it for any indication. Products sold elsewhere are typically labeled for laboratory research only, and such labels shift responsibility for safe handling to the purchaser. Because the same name covers pharmaceutical-grade nasal drops and bulk research powder, identity and purity documentation becomes the main practical concern when comparing sources.

Semax is a synthetic seven-amino-acid peptide whose sequence extends the ACTH(4-10) fragment with a C-terminal proline-glycine-proline tripeptide. The commonly cited sequence is Met-Glu-His-Phe-Pro-Gly-Pro, giving a molecular formula near C37H51N9O10S and a molecular weight close to 813.9 g/mol. It belongs to the broader class of synthetic ACTH fragments studied for central nervous system effects rather than for adrenal steroid stimulation. In practice the material appears as a lyophilized white powder for laboratory work or as a dilute saline solution in clinical settings.

Mechanisms and Research Directions

Pharmacokinetic accounts emphasize rapid breakdown. After intravenous dosing the intact peptide disappears from blood within minutes, and nasal delivery produces low but measurable concentrations. Metabolites rather than the parent molecule may account for part of the observed activity, although the relative contribution is unresolved. Dosing in the literature varies widely and no optimal schedule has been agreed. These gaps are regularly cited as a reason the findings have not produced broad clinical adoption beyond the original research setting.

Proposed mechanisms center on neurotrophic signaling rather than on classical melanocortin receptor activation. Rodent experiments have reported shifts in the expression of brain-derived neurotrophic factor and nerve growth factor after administration, together with changes in the associated receptor systems. Several authors argue that the peptide acts largely through its degradation products and their interaction with peptidergic pathways, but this remains a hypothesis rather than a settled finding. No single molecular target has been identified in a way that the field broadly accepts.

Semax at a glance

PropertyValueNotes
Chemical classSynthetic heptapeptide (ACTH fragment analog)Not a steroid; does not belong to the melanocortin agonist drugs by marketing category
Molecular formulaC37H51N9O10S (commonly cited)Reported values vary slightly with salt and counter-ion content
AppearanceWhite to off-white lyophilized powderA single batch may appear as a loose cake or fluffy solid
SolubilityFreely soluble in water and aqueous bufferStock solutions are usually prepared in sterile water or saline
Typical storage−20 °C or below, desiccated and protected from lightSeal opened vials promptly to limit moisture uptake

Semax Background And Mechanism

The proposed mechanism centres on neurotrophic signalling rather than direct receptor activation. Semax is reported to increase expression of brain-derived neurotrophic factor and nerve growth factor in several brain regions, and to shift the balance between excitatory and inhibitory neurotransmitter systems. Interaction with melanocortin receptors has been suggested because of the parent ACTH fragment. Many of these findings come from rodent studies, and the extent to which they translate to human physiology remains an open question.

Scientific literature on semax is unevenly distributed. A substantial share of published work originates from a small number of laboratories in Russia, while independent replication elsewhere is limited. Human data consist mostly of small trials with short follow-up, and several reported outcomes rely on subjective rating scales. Questions about how much intact peptide reaches the central nervous system after nasal administration, and how long it persists there, are still unresolved. The compound is best described as an active research subject rather than a settled pharmacological agent.

Related pages on this site

Handling, Storage, and Analytical Methods

Semax is supplied as a lyophilized powder that appears white to off-white. It dissolves readily in water, phosphate-buffered saline, and other aqueous media, which simplifies preparation of working solutions for laboratory use. The nasal products registered in Russia are dilute aqueous solutions, typically around 0.1 percent peptide by weight. Organic solvents are rarely necessary and can complicate handling. Because the peptide is hygroscopic, weighing should be performed quickly and with minimal exposure to ambient humidity.

Solid material is normally kept at minus 20 degrees Celsius in a sealed, desiccated container. Reconstituted solutions are less stable and are usually divided into single-use aliquots before freezing. Repeated freeze-thaw cycles are avoided because they promote aggregation and loss of activity. Light exposure is minimized by using amber glassware or foil wrapping. Published stability data for this peptide are sparse, so recommended storage conditions rest mainly on general practice for short synthetic peptides rather than on dedicated study.

Background and Development History

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Handling, Storage, and Research Status

Lyophilised powder is normally kept at -20 °C in a desiccated container, with some suppliers recommending -80 °C for long-term archival storage. Repeated freeze-thaw cycles are the most common cause of avoidable loss, so aliquoting before freezing reduces variability between working sessions. Dissolved peptide is far less stable than the dry solid and is usually prepared fresh or held briefly at 4 °C. Aqueous solutions support both hydrolysis of the backbone and oxidation of the N-terminal methionine, and these two routes dominate degradation under ordinary laboratory conditions.

Identity and purity are confirmed with reversed-phase high-performance liquid chromatography, typically monitored at 214 nanometres where the peptide bond absorbs. Mass spectrometry, either electrospray or MALDI-TOF, verifies molecular mass against the theoretical value and detects truncation or adduct formation. Amino acid analysis and peptide mapping provide additional confirmation when required. The most frequently reported impurities are deletion sequences from incomplete coupling, methionine sulfoxide from oxidation, and dimeric species formed through non-covalent aggregation. Impurity profiles depend strongly on the synthesis and purification route chosen by the producer.

Further detail

==== Dietary recommendations ==== The U.S. Institute of Medicine (IOM) updated Estimated Average Requirements (EARs) and Recommended Dietary Allowances (RDAs) for iron in 2001. The current EAR for iron for women ages 14‍–‍18 is 7.9 mg/day, 8.1 mg/day for ages 19‍–‍50 and 5.0 mg/day thereafter (postmenopause). For men, the EAR is 6.0 mg/day for ages 19 and up. The RDA is 15.0 mg/day for women ages 15‍–‍18, 18.0 mg/day for ages 19‍–‍50 and 8.0 mg/day thereafter. For men, 8.0 mg/day for ages 19 and up. RDAs are higher than EARs so as to identify amounts that will cover people with higher-than-average requirements. RDA for pregnancy is 27 mg/day and, for lactation, 9 mg/day. For children ages 1‍–‍3 years 7 mg/day, 10 mg/day for ages 4–8 and 8 mg/day for ages 9‍–‍13. As for safety, the IOM also sets Tolerable upper intake levels (ULs) for vitamins and minerals when evidence is sufficient. In the case of iron, the UL is set at 45 mg/day. Collectively the EARs, RDAs and ULs are referred to as Dietary Reference Intakes. The European Food Safety Authority (EFSA) refers to the collective set of information as Dietary Reference Values, with Population Reference Intake (PRI) instead of RDA, and Average Requirement instead of EAR. AI and UL are defined the same as in the United States. For women the PRI is 13 mg/day ages 15‍–‍17 years, 16 mg/day for women ages 18 and up who are premenopausal and 11 mg/day postmenopausal. For pregnancy and lactation, 16 mg/day. For men the PRI is 11 mg/day ages 15 and older. For children ages 1 to 14, the PRI increases from 7 to 11 mg/day.

The enzyme phenylalanine hydroxylase normally converts the amino acid phenylalanine into the amino acid tyrosine. If this reaction does not occur, phenylalanine accumulates and tyrosine is deficient. Excessive phenylalanine can be metabolized into phenylketones through the minor route, a transaminase pathway with glutamate. Metabolites include phenylacetate, phenylpyruvate and phenethylamine. Elevated levels of phenylalanine in the blood and detection of phenylketones in the urine is diagnostic, however, most patients are diagnosed via newborn screening.

Portugal, officially the Portuguese Republic, is a country in Southwestern Europe. Mainland Portugal is located on the southwestern portion of the Iberian Peninsula, and bordered by Spain to the north and east. Portugal also includes the archipelagos of Madeira and the Azores in the Atlantic Ocean. The country has a population of 11.4 million, and Lisbon, its capital, is the largest city. Portugal's internal waters and territorial sea together account for two-fifths of its territory, and its exclusive economic zone is one of Europe's largest. The country's terrain contains a diverse range of landscapes and regional climates. The western Iberian Peninsula has been inhabited since prehistory, with the earliest signs of settlement dating to between 5500 BC and 5300 BC. Muslims had occupied the Iberian Peninsula since 711. As a result of the Reconquista against them, Portugal was established as a county of the Kingdom of León in 868 and formally as a kingdom in 1179. During the Age of Discovery, the kingdom made several advancements in nautical science and maritime exploration to discover new territories and sea routes, which led to the establishment of the Portuguese Empire. The kingdom became a republic in 1910, before becoming a dictatorship in 1926, whose 1974 overthrow enabled democracy to be established in 1976. Portugal is a unitary republic and multi-party representative democracy with four separate sovereignty organs: president, government, parliament, and judiciary.

==== Pulmonary tissues ==== Lung tissue engineering focuses on developing functional respiratory structures to treat end-stage pulmonary diseases, such as chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and acute respiratory distress syndrome (ARDS). Due to the complex, highly vascularized three-dimensional architecture of the lung, which comprises over forty distinct cell types and a delicate alveolar-capillary basement membrane, whole-organ biofabrication typically relies on decellularized donor lung scaffolds. This process strips away immunogenic cellular material while preserving the native extracellular matrix geometry and mechanical compliance required for ventilation. Research strategies prioritize the multi-lineage recellularization of these scaffolds using patient-specific induced pluripotent stem cells (iPSCs) differentiated into alveolar epithelial cells (type I and II) and microvascular endothelial cells. Additionally, biomimetic microfluidic platforms, or "lung-on-a-chip" models, are utilized to study cellular shear stress and gas-exchange dynamics, serving as precursors to transplantable bioartificial lung devices.

Another less insidious tactic journals employ is to publish a large portion of its papers, or at least the papers expected to be highly cited, early in the calendar year. This gives those papers more time to gather citations. Several methods, not necessarily with nefarious intent, exist for a journal to cite articles in the same journal which will increase the journal's impact factor. Beyond editorial policies that may skew the impact factor, journals can take overt steps to game the system. For example, in 2007, the specialist journal Folia Phoniatrica et Logopaedica, with an impact factor of 0.66, published an editorial that cited all its articles from 2005 to 2006 in a protest against the "absurd scientific situation in some countries" related to use of the impact factor. The large number of citations meant that the impact factor for that journal increased to 1.44. As a result of the increase, the journal was not included in the 2008 and 2009 Journal Citation Reports. Coercive citation is a practice in which an editor forces an author to add extraneous citations to an article before the journal will agree to publish it, in order to inflate the journal's impact factor. A survey published in 2012 indicates that coercive citation has been experienced by one in five researchers working in economics, sociology, psychology, and multiple business disciplines, and it is more common in business and in journals with a lower impact factor. Editors of leading business journals banded together to disavow the practice.

Sources: en.wikipedia.org

Background from the literature

Spironolactone has been found to decrease the bioavailability of high doses of oral estradiol. Although widely employed, the use of spironolactone as an antiandrogen in transgender women has recently been questioned due to the various shortcomings of the medication for such purposes. Cyproterone acetate is an antiandrogen and progestin which is used in the treatment of numerous androgen-dependent conditions and is also used as a progestogen in birth control pills. It works primarily as an antigonadotropin, secondarily to its potent progestogenic activity, and strongly suppresses gonadal androgen production. Cyproterone acetate at a dosage of 5 to 10 mg/day has been found to lower testosterone levels in men by about 50 to 70%, while a dosage of 100 mg/day has been found to lower testosterone levels in men by about 75%. The combination of 25 mg/day cyproterone acetate and a moderate dosage of estradiol has been found to suppress testosterone levels in transgender women by about 95%. In combination with estrogen, 10, 25, and 50 mg/day cyproterone acetate have all shown the same degree of testosterone suppression. In addition to its actions as an antigonadotropin, cyproterone acetate is an androgen receptor antagonist. However, this action is relatively insignificant at low dosages, and is more important at the high doses of cyproterone acetate that are used in the treatment of prostate cancer (100–300 mg/day). Cyproterone acetate can cause elevated liver enzymes and liver damage, including liver failure.

=== Rail === Bromley is served by two main rail stations. Bromley South provides National Rail services to London Victoria (non stop, semi fast via Denmark Hill and stopping services via Herne Hill), London Blackfriars via Catford, Orpington, Sevenoaks via Swanley, Ramsgate via Chatham, Dover Priory via Chatham & Canterbury East and to Ashford International via Maidstone East. Bromley North provides shuttle services to Grove Park, where onward connections can be made for services to London Charing Cross & London Cannon Street via Lewisham. Finally, Shortlands railway station serves primarily residential areas immediately southwest of the town centre. Being one stop west of Bromley South, Southeastern and Thameslink services connect the station to London Victoria and London Blackfriars.

The mouse has since been used extensively as a model organism and is associated with many important biological discoveries of the 20th and 21st centuries. The Jackson Laboratory in Bar Harbor, Maine is currently one of the world's largest suppliers of laboratory mice, supplying around 3 million mice a year. The laboratory is also the world's source for more than 8,000 strains of genetically defined mice and is home of the Mouse Genome Informatics database.

The Metropolitan Police apologise to Doreen Lawrence after failing to provide information about a suspect in her son's murder. Drivers at 16 train operators announce a series of one-day rolling strikes between 7 and 9 May. Co-op Live announces the postponement of its opening events starring Peter Kay as the venue is not ready. 23 April Office for National Statistics data indicates UK government borrowing was at £120.7bn in March 2024, lower than the figure for the same time the previous year, but £6.6bn higher than the government's forecasts. Five migrants including a child are reported to have died attempting to cross the English Channel in a small boat, just hours after passage of the Rwanda Bill. Sunak pledges an additional £500m to support Ukraine, on top of the £2.5bn allocated for this financial year. Sunak announces "the biggest strengthening of our national defence in a generation, to meet the challenge of an increasingly dangerous world". He confirms that defence spending will increase from 2.3% of gross domestic product (GDP) to 2.5% by 2030, meaning an extra £75bn for the military over the next six years. 24 April Four people are injured and several vehicles are damaged as a number of runaway horses – one seemingly covered in blood – escape from the Household Cavalry and gallop through central London. Three people are injured and one arrested after a stabbing incident at a school in Ammanford, Wales. Unions say that 70,000 civil service jobs will be cut in order to fund an increase in defence spending.

Sources: en.wikipedia.org

Reference notes

Conservative leader Kemi Badenoch outlines her party's immigration policy, which reaffirms its commitment to a "strict migration cap"; she also says that her party got it "wrong" on immigration while in government. MPs will debate an online petition calling for a re-run of the 2024 general election in Westminster Hall, a secondary debating chamber, on 6 January 2025 after the petition attracted 2.8 million signatures. 28 November – Former prime minister David Cameron announces his support for an assisted dying law in the UK. Transport Secretary Louise Haigh reveals that she pleaded guilty to falsely saying a mobile phone had been stolen during a mugging before she became an MP and was given an absolute discharge by magistrates. Unite the Union announces plans to proceed with a legal challenge to overturn the UK government's cuts to Winter Fuel Payments. The Scottish Government announces that all pensioner households will receive a Winter Fuel Payment from Winter 2025–26, with those on Pension Credit receiving £200 or £300 dependent on age and the rest receiving £100. Former Conservative MP Andrea Jenkyns defects to Reform UK, and announces plans to run as Mayor of Greater Lincolnshire in May 2025. BBC News Wales reports that Senedd Conservatives will hold a vote of confidence in Welsh Conservative leader Andrew RT Davies on 3 December following a series of criticisms about his leadership. Mauritian prime minister Navin Ramgoolam asks for an independent review of the UK's deal with his country over sovereignty of the Chagos Islands.

Various composers have created the film and television scores of the MCU films, television series, One-Shots, Special Presentations, and other related projects of the MCU, primarily released by Marvel Studios's record label Marvel Music. Original songs have also been created specifically for use in the franchise, while Brian Tyler and Michael Giacchino have both scored fanfares for the Marvel Studios production logo.

Californium is a synthetic chemical element; it has symbol Cf and atomic number 98. It was first synthesized in 1950 at Lawrence Berkeley National Laboratory (then the University of California Radiation Laboratory) by bombarding curium with alpha particles (helium-4 ions). It is an actinide element, the sixth transuranium element to be synthesized, and has the second-highest atomic mass of all elements that have been produced in amounts large enough to see with the naked eye (after einsteinium). It was named after the university and the U.S. state of California. Two crystalline forms exist at normal pressure: one above and one below 900 °C (1,650 °F). A third form exists at high pressure. Californium slowly tarnishes in air at room temperature. Californium compounds are dominated by the +3 oxidation state. The most stable of californium's twenty known isotopes is californium-251, with a half-life of 898 years. This short half-life means the element is not found in significant quantities in the Earth's crust. 252Cf, with a half-life of about 2.645 years, is the most common isotope used and is produced at Oak Ridge National Laboratory (ORNL) in the United States and Research Institute of Atomic Reactors in Russia. Californium is one of the few transuranium elements with practical uses. Most of these applications exploit the fact that certain isotopes of californium emit neutrons. For example, californium can be used to help start up nuclear reactors, and it is used as a source of neutrons when studying materials using neutron diffraction and neutron spectroscopy.

Sources: en.wikipedia.org

Frequently asked questions

What is Semax made of?

It is a short synthetic peptide built from seven amino acids: methionine, glutamic acid, histidine, phenylalanine and three prolines. The sequence derives from the 4-10 fragment of adrenocorticotropic hormone with an added proline-glycine-proline tail. No plant or animal extract is involved; the material is produced by solid-phase peptide synthesis.

Where did Semax originate?

It was developed in the Soviet Union during the early 1980s by groups at the Institute of Molecular Genetics in Moscow. Russian approval for intranasal use followed, and it has been marketed there since. Western laboratories encountered it mainly through translated literature and, later, through online research-chemical trade.

Is Semax a licensed medicine?

It holds a Russian registration as a prescription nasal product but has no approval from the European Medicines Agency or the United States Food and Drug Administration. Buyers outside Russia usually receive material sold strictly for laboratory research. That distinction matters because research-grade and pharmaceutical-grade products carry different documentation and testing expectations.

What is the leading proposed mechanism?

The main proposal is modulation of neurotrophic factors such as brain-derived neurotrophic factor, supported largely by animal experiments. Receptor-level targets have not been firmly established. Most reviews describe the mechanism as only partially characterized.

Network